radionuclides applied oncology diagnosis therapy demands radionuclides labeling specific substrates localizing malignant tissue analyzing tumor metabolism vivo positron emission tomography pet register vivo metabolism example glucose amino acids receptors potentially useful cytotoxic agents advantage positron emitting radionuclides carbon nitrogen fluorine labeling substrates changing substrate specificity metabolic reaction chain substrate concentration situ quantified regard therapy radionuclides emit decay electron capture auger effect administered ionic form tumor seeking substrates examples radioiodine treating thyroid malignancy radiophosphorus myeloproliferative diseases organically bound radionuclides given labeled ligands specific receptors mibg treating catecholamine producing tumors phaeochromocytoma neuroblastoma labeled monoclonal antibodies tumors specific receptors highly localized energy depositions come auger emitters 125i neutron capture therapy tumor cell exposed thermal neutrons initiating b10 n alpha li7 reaction especially treating glioblastoma melanoma endogenous radiotherapy radionuclides rely success delivering proper energy individual tumor cells optimal protection normal tissue inevitable heterogeneity energy deposition events approaches demands careful dosimetric assessment classical methods dosimetry percutaneous radiotherapy applicable gamma emitting beta alpha particles meta iodo benzylguanidine boron NUMBER neuro